These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27532743)

  • 1. Oral Endocrine Therapy Nonadherence, Adverse Effects, Decisional Support, and Decisional Needs in Women With Breast Cancer.
    Milata JL; Otte JL; Carpenter JS
    Cancer Nurs; 2018; 41(1):E9-E18. PubMed ID: 27532743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors.
    Paranjpe R; John G; Trivedi M; Abughosh S
    Breast Cancer Res Treat; 2019 Apr; 174(2):297-305. PubMed ID: 30523459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
    Hwang GS; Paranjpe R; Opsomer C; Lu K; Abajue U; Abughosh S; Zaghloul H; Trivedi MV
    Clin Breast Cancer; 2020 Dec; 20(6):520-526. PubMed ID: 32669209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for nonadherence to tamoxifen and aromatase inhibitors for the treatment of breast cancer: a literature review.
    Sawesi S; Carpenter JS; Jones J
    Clin J Oncol Nurs; 2014 Jun; 18(3):E50-7. PubMed ID: 24867124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists.
    Biglia N; Bounous VE; D'Alonzo M; Ottino L; Tuninetti V; Robba E; Perrone T
    Clin Breast Cancer; 2017 Dec; 17(8):611-617. PubMed ID: 28655486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative review of breast cancer survivors' transition experience and transitional care: dialog with transition theory perspectives.
    Chao YH; Wang SY; Sheu SJ
    Breast Cancer; 2020 Sep; 27(5):810-818. PubMed ID: 32372320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to endocrine therapy for breast cancer.
    Chlebowski RT; Geller ML
    Oncology; 2006; 71(1-2):1-9. PubMed ID: 17344666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
    Bromley SE; Matthews A; Smeeth L; Stanway S; Bhaskaran K
    J Cancer Surviv; 2019 Aug; 13(4):632-640. PubMed ID: 31321612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to long-term adjuvant hormonal therapy for breast cancer.
    Gotay C; Dunn J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-15. PubMed ID: 22098287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
    Santen RJ
    J Clin Endocrinol Metab; 2011 Feb; 96(2):308-19. PubMed ID: 21147884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry.
    Stanton AL; Petrie KJ; Partridge AH
    Breast Cancer Res Treat; 2014 Jun; 145(2):525-34. PubMed ID: 24781972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.
    Baglia ML; Lin IH; Cartmel B; Sanft T; Ligibel J; Hershman DL; Harrigan M; Ferrucci LM; Li FY; Irwin ML
    Cancer; 2019 Jul; 125(13):2262-2271. PubMed ID: 30840336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
    Tjan-Heijnen VCG; van Hellemond IEG; Peer PGM; Swinkels ACP; Smorenburg CH; van der Sangen MJC; Kroep JR; De Graaf H; Honkoop AH; Erdkamp FLG; van den Berkmortel FWPJ; de Boer M; de Roos WK; Linn SC; Imholz ALT; Seynaeve CM;
    Lancet Oncol; 2017 Nov; 18(11):1502-1511. PubMed ID: 29031778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.
    Simon R; Latreille J; Matte C; Desjardins P; Bergeron E
    Can J Surg; 2014 Feb; 57(1):26-32. PubMed ID: 24461223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.
    Aiello Bowles EJ; Boudreau DM; Chubak J; Yu O; Fujii M; Chestnut J; Buist DS
    J Oncol Pract; 2012 Nov; 8(6):e149-57. PubMed ID: 23598850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors.
    Uslu Y; Kocatepe V; Sezgin DS; Uras C
    Support Care Cancer; 2023 Apr; 31(5):285. PubMed ID: 37079089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Rickett K; Feng S; Vagenas D; Woodward NE
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012988. PubMed ID: 31994181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.
    Perez EA
    Ann Oncol; 2007 Sep; 18 Suppl 8():viii26-35. PubMed ID: 17890211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.